Glycaemic outcomes of an Individualised treatMent aPproach for oldER vulnerable patIents: A randomised, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM)

July 24, 2017

Source: Diabetes, Obesity and Metabolism

Follow this link to read an abstract

Date of publication: July 17

Publication type: Journal article

In a nutshell: To compare the glycaemic outcomes of 2 glucose-lowering treatment strategies in vulnerable (moderately ill and/or frail) patients aged ≥65 years with type 2 diabetes whose individual HbA1c targets were not met with diet/exercise and/or oral antihyperglycaemic medications (OAMs).

Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/


Body mass index and all-cause mortality among type 2 diabetes mellitus patients

July 24, 2017

Source: European Journal of Internal Medicine

Follow this link to read an abstract

Date of publication: July 17

Publication type: Journal article

In a nutshell: In an outpatient T2DM Mediterranean population sample, low BMI predicted all-cause mortality only in males.

Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/


Incretin based treatments and mortality in patients with type 2 diabetes

July 24, 2017

Source: BMJ

Follow this link to read an abstract

Date of publication: June 17

Publication type: Journal article

In a nutshell: To assess the impact of incretin based treatment on all cause mortality in patients with type 2 diabetes.

Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/


Impact of mulberry leaf extract on type 2 diabetes

July 24, 2017

Source: Complementary Therapies in Medicine

Follow this link to read an abstract

Date of publication: June 17

Publication type: Journal article

In a nutshell: Mulberry leaves have been used anecdotally in Asia to treat many disease states, including glucose abnormalities. Animal and human studies illustrate potential benefit of mulberry leaf extract (MLE) in type 2 diabetes mellitus (DM2). The purpose of this study is to evaluate the glycemic and safety effects of MLE in patients with DM2.

Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/


Whose diabetes is it anyway?

June 19, 2017

Source: Practical Diabetes

Follow this link to read an abstract

Date of publication: June 17

Publication type: Journal article

In a nutshell: The contribution and sometimes overlooked resource of the dietitian within the diabetes team;
the untapped potential of the person with diabetes and the importance of supporting them to develop the knowledge, skills and confidence to live well with their diabetes;
the importance of systematic high-quality services designed around the needs of the individual.

Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/


Factors determining uptake of diabetic retinopathy screening

June 19, 2017

Source: Diabetic Medicine

Follow this link to read an abstract

Date of publication: July 17

Publication type: Journal article

In a nutshell: To investigate variables at the demographic and primary care practice levels that influence the uptake of diabetic retinopathy screening.

Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/


Novel therapies in type 2 diabetes: insulin resistance

June 19, 2017

Source: Practical Diabetes

Follow this link to read an abstract

Date of publication: June 17

Publication type: Journal article

In a nutshell: Insulin resistance plays an important role in the pathogenesis of type 2 diabetes and cardiovascular disease. Obesity is a major risk factor for the development of insulin resistance. Hence, treating obesity with lifestyle interventions is the cornerstone of managing insulin resistance.

Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/